Cannabinoids and multiple sclerosis (Q34786839)

4 August 2017

1 reference

title

Cannabinoids and multiple sclerosis. (English)

1 reference

4 August 2017

0 references

0 references

Roger G Pertwee

1

1 reference

4 August 2017

1 August 2002

1 reference

Pharmacology & Therapeutics

4 August 2017

1 reference

4 August 2017

95

1 reference

4 August 2017

165-174

1 reference

4 August 2017

2

1 reference

Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Cannabinoids control spasticity and tremor in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Endocannabinoids control spasticity in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Control of pain initiation by endogenous cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Tetrahydrocannabinol for tremor in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

The perceived effects of smoked cannabis on patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

The perceived effects of marijuana on spinal cord injured males

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Pain relief with oral cannabinoids in familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Evaluation of intramuscular levonantradol and placebo in acute postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Nabilone in the treatment of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Effect of cannabinoids on spasticity and ataxia in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

The analgesic properties of delta-9-tetrahydrocannabinol and codeine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Analgesic Effect of Delta‐9‐Tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

The central neuropharmacology of psychotropic cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Cannabinoid receptors and pain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

(+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-delta8-tetrahydrocannabinol at cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Antimicrobial and respiratory burst characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco, and nonsmokers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Inhibitory effects of SR141716A on G-protein activation in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Cannabinoid-induced enhancement and depression of cat monosynaptic reflexes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Effects of δ9-Tetrahydrocannabinol on cat spinal motoneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Cannabidiol-caused depression of spinal motoneuron responses in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Anandamide, a naturally-occurring agonist of the cannabinoid receptor, blocks adenylate cyclase at the frog neuromuscular junction.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

Suppression of experimental autoimmune encephalomyelitis by cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

[Results of a standardized survey on the medical use of cannabis products in the German-speaking area].

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900255-3

7 January 2021

10.1016/S0163-7258(02)00255-3

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12182963